These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 21488768)

  • 1. Case records of the Massachusetts General Hospital. Case 11-2011. A 47-year-old man with systemic lupus erythematosus and heart failure.
    Newton-Cheh C; Lin AE; Baggish AL; Wang H
    N Engl J Med; 2011 Apr; 364(15):1450-60. PubMed ID: 21488768
    [No Abstract]   [Full Text] [Related]  

  • 2. Restrictive cardiomyopathy secondary to hydroxychloroquine therapy.
    Manohar VA; Moder KG; Edwards WD; Klarich K
    J Rheumatol; 2009 Feb; 36(2):440-1. PubMed ID: 19208570
    [No Abstract]   [Full Text] [Related]  

  • 3. Hydroxychloroquine: a treatable cause of cardiomyopathy.
    Abbasi S; Tarter L; Farzaneh-Far R; Farzaneh-Far A
    J Am Coll Cardiol; 2012 Aug; 60(8):786. PubMed ID: 22898072
    [No Abstract]   [Full Text] [Related]  

  • 4. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 38-1988. A 58-year-old woman with fever, sweats, congestive heart failure, and lymphadenopathy after treatment for a diagnosis of systemic lupus erythematosus.
    N Engl J Med; 1988 Sep; 319(12):768-81. PubMed ID: 3412398
    [No Abstract]   [Full Text] [Related]  

  • 5. [Proximal myopathy and fulminant heart failure in a 57 year-old female patient with lupus erythematosus].
    Wille F; Birkmeier S; Tiemann K; Lewalter T; Klingel K; Rabe C; Sick P
    Internist (Berl); 2020 Aug; 61(8):854-859. PubMed ID: 32504300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New clinical and ultrastructural findings in hydroxychloroquine-induced cardiomyopathy--a report of 2 cases.
    Soong TR; Barouch LA; Champion HC; Wigley FM; Halushka MK
    Hum Pathol; 2007 Dec; 38(12):1858-63. PubMed ID: 18061791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for risk of cardiomyopathy with hydroxychloroquine.
    Sumpter MD; Tatro LS; Stoecker WV; Rader RK
    Lupus; 2012 Dec; 21(14):1594-6. PubMed ID: 23036986
    [No Abstract]   [Full Text] [Related]  

  • 8. Heart Involvement in a Woman Treated with Hydroxychloroquine for Systemic Lupus Erythematosus Revealing Fabry Disease.
    Chatre C; Filippi N; Roubille F; Pers YM
    J Rheumatol; 2016 May; 43(5):997-8. PubMed ID: 27134281
    [No Abstract]   [Full Text] [Related]  

  • 9. Hydroxychloroquine-induced cardiomyopathy: a case report.
    Muthukrishnan P; Roukoz H; Grafton G; Jessurun J; Colvin-Adams M
    Circ Heart Fail; 2011 Mar; 4(2):e7-8. PubMed ID: 21406675
    [No Abstract]   [Full Text] [Related]  

  • 10. Hydroxychloroquine-induced cardiomyopathy: case report, pathophysiology, diagnosis, and treatment.
    Yogasundaram H; Putko BN; Tien J; Paterson DI; Cujec B; Ringrose J; Oudit GY
    Can J Cardiol; 2014 Dec; 30(12):1706-15. PubMed ID: 25475472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relapsed hydroxychloroquine induced thrombocytopenia in a systemic lupus erythematosus patient.
    Antón Vázquez V; Pascual L; Corominas H; Giménez Torrecilla I
    Reumatol Clin; 2017; 13(5):294-296. PubMed ID: 27263963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydroxychloroquine cardiotoxicity in systemic lupus erythematosus: a report of 2 cases and review of the literature.
    Nord JE; Shah PK; Rinaldi RZ; Weisman MH
    Semin Arthritis Rheum; 2004 Apr; 33(5):336-51. PubMed ID: 15079764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydroxychloroquine-induced cardiomyopathy accelerated after gastric banding.
    Lodge FM; Moody WE; Tosounidou S; Chue CD; Curtis E; Neil DAH; Bradlow W
    Lancet; 2021 Nov; 398(10314):1913. PubMed ID: 34801107
    [No Abstract]   [Full Text] [Related]  

  • 14. Hydroxychloroquine-induced cardiotoxicity in a 39-year-old woman with systemic lupus erythematosus and systolic dysfunction.
    Keating RJ; Bhatia S; Amin S; Williams A; Sinak LJ; Edwards WD
    J Am Soc Echocardiogr; 2005 Sep; 18(9):981. PubMed ID: 16153529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Left Ventricular noncompaction in a patient with systemic lupus erythematosus.
    Dobranici M; Tocitu A; Delcea C; Dan GA
    Rom J Intern Med; 2019 Mar; 57(1):78-82. PubMed ID: 30379642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ototoxicity due to hydroxychloroquine: report of two cases.
    Johansen PB; Gran JT
    Clin Exp Rheumatol; 1998; 16(4):472-4. PubMed ID: 9706431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydroxycholoroquine-induced hyperpigmentation.
    Mir A; Boyd KP; Meehan SA; McLellan B
    Dermatol Online J; 2013 Dec; 19(12):20723. PubMed ID: 24365014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydroxychloroquine-induced seizure in a patient with systemic lupus erythematosus.
    Malcangi G; Fraticelli P; Palmieri C; Cappelli M; Danieli MG
    Rheumatol Int; 2000 Dec; 20(1):31-3. PubMed ID: 11149659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Renal infarction in systemic lupus with antiphospholipid syndrome: role of hydroxychloroquine withdrawal? Comment on the article by Szymezak et al].
    Zenone T; Knefati Y
    Rev Med Interne; 2011 Apr; 32(4):261-2. PubMed ID: 21330018
    [No Abstract]   [Full Text] [Related]  

  • 20. Successful desensitization for hydroxychloroquine anaphylaxis.
    Donado CD; Díez EM
    J Rheumatol; 2010 Sep; 37(9):1975-6. PubMed ID: 20810530
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.